Apollo Hospitals

Why is Apollo Hospitals Enterprise Ltd. falling/rising?

As of 22-Jun, Apollo Hospitals Enterprise Ltd. is experiencing a slight decline in its stock price, currently at Rs 8,471.20, but has shown strong long-term performance with a year-to-date increase of 20.29%. Despite a minor short-term drop, investor interest remains high, indicating a resilient market position.

As of 22-Jun, Apollo Hospitals Enterprise Ltd. is experiencing a slight decline in its stock price, currently at Rs 8,471.20, which reflects a change of -25.6 (-0.3%). Despite this decrease, the stock has shown strong performance over the longer term, with a year-to-date increase of 20.29%, significantly outperforming the Sensex, which has fallen by 9.54% during the same period. <BR><BR>The stock is currently just 1.7% away from its 52-week high of Rs 8,624.2, indicating that it has been trading near its peak value. However, on the day of the report, it underperformed its sector by 0.95%. This short-term decline may be attributed to market fluctuations rather than fundamental weaknesses, as the company has demonstrated high management efficiency with a return on capital employed (ROCE) of 17.13% and consistent positive results over the last ten quarters.<BR><BR>Investor participation appears to be increasing, with delivery volume rising by 17.17% against the five-day average, suggesting that while the stock is currently falling, there is still significant interest from investors. The stock's liquidity is also favorable, allowing for substantial trade sizes. Overall, while the stock is facing a minor decline at the moment, its strong historical performance and positive growth indicators suggest a resilient position in the market.

Which are the latest news on Apollo Hospitals?

How big is Apollo Hospitals?

As of 10th June, Apollo Hospitals Enterprise Ltd. has a market capitalization of 123,813.00 Cr, with recent net sales of 25,228.50 Cr and a net profit of 1,941.60 Cr. The company reported shareholder's funds of 8,212.30 Cr and total assets of 20,644.30 Cr for the latest annual period ending March 2025.

As of 10th June, Apollo Hospitals Enterprise Ltd. has a market capitalization of 123,813.00 Cr, categorizing it as a Large Cap company.<BR><BR>In the latest four quarters, Apollo Hospitals reported Net Sales of 25,228.50 Cr and a Net Profit of 1,941.60 Cr.<BR><BR>For the latest annual period ending March 2025, the company had Shareholder's Funds of 8,212.30 Cr and Total Assets amounting to 20,644.30 Cr.

Who are in the management team of Apollo Hospitals?

The management team of Apollo Hospitals includes Executive Chairman Prathap C Reddy, Executive Vice Chairpersons Preetha Reddy and Shobana Kamineni, Managing Director Suneeta Reddy, Joint Managing Director Sangita Reddy, and Senior Vice President S M Krishnan, along with several independent directors. This team is responsible for overseeing the operations and strategic direction of the organization.

The management team of Apollo Hospitals includes the following key individuals:<BR><BR>1. **Prathap C Reddy** - Executive Chairman<BR>2. **Preetha Reddy** - Executive Vice Chairperson<BR>3. **Suneeta Reddy** - Managing Director<BR>4. **Sangita Reddy** - Joint Managing Director<BR>5. **Shobana Kamineni** - Executive Vice Chairperson<BR>6. **S M Krishnan** - Senior Vice President & Company Secretary<BR><BR>Additionally, the board features several independent directors:<BR>- **Vinayak Chatterjee**<BR>- **Murali Doraiswamy**<BR>- **V Kavitha Dutt**<BR>- **M B N Rao** - Lead Independent Director<BR>- **Som Mittal**<BR>- **Rama Bijapurkar**<BR><BR>This team plays a crucial role in overseeing the operations and strategic direction of Apollo Hospitals.

Who are the peers of the Apollo Hospitals?

Apollo Hospitals' peers include Max Healthcare, Fortis Health, Aster DM Health, Narayana Hrudaya, Global Health, Krishna Institute, Dr. Agarwal's Health, Rainbow Children, and Health.Global. Apollo Hospitals shows excellent management and growth, with a 1-year return of 22.24%, while Aster DM Health leads with a 42.39% return.

Peers: The peers of Apollo Hospitals are Max Healthcare, Fortis Health., Aster DM Health., Narayana Hrudaya, Global Health, Krishna Institu., Dr Agarwal's Hea, Rainbow Child., and Health.Global.<BR><BR>Quality Snapshot: Excellent management risk is observed at Apollo Hospitals, Narayana Hrudaya, Global Health, Krishna Institu., and Rainbow Child., while Average management risk is found at Max Healthcare, Fortis Health., Dr Agarwal's Hea, and Health.Global. Growth is excellent for Apollo Hospitals, Max Healthcare, Fortis Health., and Narayana Hrudaya, while Aster DM Health., Global Health, Krishna Institu., and Rainbow Child. show below average growth. Average capital structure is noted for Apollo Hospitals, Aster DM Health., and Health.Global, while excellent capital structure is seen at Max Healthcare and Global Health, with good capital structure at Fortis Health., Narayana Hrudaya, Dr Agarwal's Hea, Krishna Institu., and Rainbow Child.<BR><BR>Return Snapshot: Aster DM Health. has the highest 1-year return at 42.39%, while Max Healthcare has the lowest at -14.64%. Apollo Hospitals' 1-year return of 22.24% is higher than Max Healthcare's but lower than Aster DM Health.'s. Additionally, Max Healthcare, Dr Agarwal's Hea, and Health.Global have negative six-month returns.

What does Apollo Hospitals do?

Apollo Hospitals Enterprise Ltd. is a leading private healthcare provider in Asia, with a market cap of INR 123,813 Cr and reported net sales of 6,606 Cr and net profit of 529 Cr for the quarter ending March 2026. Key metrics include a P/E ratio of 62.00 and a return on equity of 20.63%.

Overview:<BR>Apollo Hospitals Enterprise Ltd. is a leading private sector healthcare provider in Asia, operating within the hospital industry and classified as a large-cap company.<BR><BR>History:<BR>Apollo Hospitals Enterprise Ltd. was incorporated in an unspecified year and has maintained its status as a prominent healthcare provider. The latest quarterly results reported net sales and net profit for the period ending March 2026.<BR><BR>Financial Snapshot:<BR>- Net Sales: 6,606 Cr (Quarterly Results - Mar 2026)<BR>- Net Profit: 529 Cr (Quarterly Results - Mar 2026)<BR>- Market Cap: INR 123,813 Cr (Large Cap)<BR><BR>Key Metrics:<BR>- P/E: 62.00<BR>- Industry P/E: 60<BR>- Dividend Yield: 0.23%<BR>- Debt Equity: 0.67<BR>- Return on Equity: 20.63%<BR>- Price to Book: 12.93<BR><BR>Contact Details:<BR>Address: No 19 Bishop Garden, Raja Annamalaipuram Chennai Tamil Nadu : 600028<BR>Tel: 91-44-28290956/28293896<BR>Email: apolloshares@vsnl.net<BR>Website: http://www.apollohospitals.com

Are Apollo Hospitals Enterprise Ltd. latest results good or bad?

Apollo Hospitals Enterprise Ltd. reported strong results for the March 2026 quarter, with net sales of ₹6,605.50 crores and a net profit of ₹529.30 crores, reflecting significant year-on-year growth and improved operational efficiency. Overall, the results are considered good, showcasing the company's solid performance in the healthcare sector.

Apollo Hospitals Enterprise Ltd. has reported strong results for the March 2026 quarter, indicating good performance. The company achieved net sales of ₹6,605.50 crores, reflecting a sequential growth of 1.98% and an impressive year-on-year increase of 18.12%. This marks an all-time high for net sales, showcasing Apollo's ability to expand its operations effectively.<BR><BR>The net profit for the quarter stood at ₹529.30 crores, which is a 5.38% increase compared to the previous quarter and a significant 35.86% increase year-on-year. Additionally, the operating margin improved to 15.31%, the highest in recent quarters, indicating enhanced operational efficiency.<BR><BR>Overall, Apollo Hospitals' financial performance demonstrates consistent growth, strong profitability metrics, and effective cost management, positioning the company favorably within the healthcare sector. The results can be considered good, reflecting the company's solid execution capabilities and favorable industry dynamics.

Should I buy, sell or hold Apollo Hospitals Enterprise Ltd.?

When is the next results date for Apollo Hospitals Enterprise Ltd.?

The next results date for Apollo Hospitals Enterprise Ltd. is 20 May 2026.

The next results date for Apollo Hospitals Enterprise Ltd. is scheduled for 20 May 2026.

Has Apollo Hospitals Enterprise Ltd. declared dividend?

Yes, Apollo Hospitals Enterprise Ltd. has declared a dividend of 200%, amounting to ₹10 per share, with an ex-date of February 16, 2026. The dividend yield is 0.25%, contributing to positive total returns across various periods.

Apollo Hospitals Enterprise Ltd. has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 200%<BR>- Amount per share: 10<BR>- Ex-date: 16 Feb 26<BR><BR>Dividend Yield: 0.25%.<BR><BR>Total Returns by Period:<BR>In the 3 Months period, the price return was 0.52%, the dividend return was 0.13%, resulting in a total return of 0.65%.<BR><BR>In the 6 Months period, the price return was 4.21%, the dividend return was 0.25%, leading to a total return of 4.46%.<BR><BR>In the 1 Year period, the price return was 17.92%, the dividend return was 0.32%, culminating in a total return of 18.24%.<BR><BR>In the 2 Years period, the price return was 13.99%, the dividend return was 0.58%, resulting in a total return of 14.57%.<BR><BR>In the 3 Years period, the price return was 70.71%, the dividend return was 1.23%, leading to a total return of 71.94%.<BR><BR>In the 4 Years period, the price return was 66.7%, the dividend return was 1.54%, culminating in a total return of 68.24%.<BR><BR>In the 5 Years period, the price return was 174.48%, the dividend return was 2.57%, resulting in a total return of 177.05%.<BR><BR>Overall, Apollo Hospitals Enterprise Ltd. has declared a significant dividend, which contributes to its total returns across various periods, indicating a strong performance in both price appreciation and dividend distribution.

Is Apollo Hospitals technically bullish or bearish?

As of December 3, 2025, Apollo Hospitals shows a mildly bearish trend, driven by bearish signals from the MACD, KST, and OBV on weekly and monthly charts, despite some mixed indicators from Bollinger Bands and daily moving averages.

As of 3 December 2025, the technical trend for Apollo Hospitals has changed from sideways to mildly bearish. The current technical stance is mildly bearish. Key indicators driving this stance include the MACD on both weekly and monthly time frames showing mildly bearish signals, along with the KST and OBV also indicating mild bearishness on the weekly and monthly charts. The Bollinger Bands present a mixed view, being bearish on the weekly but mildly bullish on the monthly. The daily moving averages suggest a mildly bullish position, but this is overshadowed by the overall bearish indicators in the longer time frames.

How has been the historical performance of Apollo Hospitals?

Apollo Hospitals has shown consistent growth in net sales and profitability, with net sales increasing from 9,617.44 Cr in Mar'19 to 21,794.00 Cr in Mar'25, and profit after tax rising from 199.18 Cr to 1,472.10 Cr in the same period. The company has also improved its earnings per share from 16.97 to 100.55 and demonstrated strong asset growth.

Answer:<BR>The historical performance of Apollo Hospitals shows a consistent growth trajectory in net sales and profitability over the years.<BR><BR>Breakdown:<BR>Apollo Hospitals has demonstrated significant growth in net sales, increasing from 9,617.44 Cr in Mar'19 to 21,794.00 Cr in Mar'25. The total operating income followed a similar trend, reaching 21,794.00 Cr in Mar'25, up from 16,612.50 Cr in Mar'23. The operating profit (PBDIT) also rose notably, from 1,095.10 Cr in Mar'19 to 3,222.10 Cr in Mar'25, reflecting an operating profit margin of 13.87% in the latest year. Profit before tax surged to 2,006.10 Cr in Mar'25, with profit after tax reaching 1,472.10 Cr, marking a significant increase from 199.18 Cr in Mar'19. The earnings per share (EPS) improved dramatically from 16.97 in Mar'19 to 100.55 in Mar'25. On the balance sheet, total assets grew from 11,288.80 Cr in Mar'20 to 20,644.30 Cr in Mar'25, while total liabilities increased from 11,288.80 Cr to 20,644.30 Cr in the same period. Cash flow from operating activities has also shown positive growth, reaching 2,136.00 Cr in Mar'25, contributing to a closing cash balance of 578.00 Cr. Overall, Apollo Hospitals has exhibited robust financial performance with increasing revenues, profits, and asset growth over the years.

Is Apollo Hospitals overvalued or undervalued?

As of October 30, 2025, Apollo Hospitals is considered undervalued with an attractive valuation grade, featuring a PE ratio of 71.16, a lower PEG ratio of 1.37 compared to peers, and an 11.30% return over the past year, outperforming the Sensex's 5.58%.

As of 30 October 2025, Apollo Hospitals has moved from a fair to an attractive valuation grade, indicating a shift in its perceived value. The company is currently considered undervalued, particularly when compared to its peers. Key ratios include a PE ratio of 71.16, an EV to EBITDA of 36.59, and a ROE of 17.61%. <BR><BR>In comparison to its peers, Apollo Hospitals stands out with a lower PEG ratio of 1.37, while competitors such as Max Healthcare and Fortis Health are deemed very expensive with PE ratios of 94.85 and 85.21, respectively. Additionally, despite a slight decline in the past week, Apollo Hospitals has outperformed the Sensex over the past year with a return of 11.30% compared to the Sensex's 5.58%, reinforcing its attractive valuation in the current market.

Who are the top shareholders of the Apollo Hospitals?

The top shareholders of Apollo Hospitals include M/s. Pcr Investments Ltd with 18.93%, Foreign Institutional Investors holding 43.49%, and mutual funds with 15.94%. The highest public shareholder is Mirae Asset Midcap Fund at 2.21%, while individual investors own 3.98%.

The top shareholders of Apollo Hospitals include a mix of institutional and individual investors. The largest shareholder is M/s. Pcr Investments Ltd, which holds 18.93% of the company. Foreign Institutional Investors (FIIs) are significant stakeholders, collectively holding 43.49%. Additionally, mutual funds are represented by 324 schemes, accounting for 15.94% of the shares. The highest public shareholder is Mirae Asset Midcap Fund, with a holding of 2.21%. Individual investors collectively own 3.98% of the company.